Dr. Reddy’s Laboratories received approval of XEGLYZE™ (abametapir) lotion, 0.74%, in the U.S.
Hyderabad, India and Princeton, NJ, USA., July 27, 2020 – Dr Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr Reddy’s”) today announced approval of […]